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Background: Atrial enlargementmay reﬂect ventricular diastolic dysfunction. Although patientswith tetralogy of
Fallot (TOF) have been studied extensively, little is known about atrial size and function. We assessed bi-atrial
size and function in patients after TOF repair, and related them to biventricular systolic and diastolic function,
and clinical parameters.
Methods: 51 Patients (21±8 years) and 30 healthy controls (31±7 years) were included and underwent mag-
netic resonance imaging to assess bi-atrial and biventricular size, systolic and diastolic function. Patients also
underwent exercise testing, and N-terminal prohormone brain natriuretic peptide (NT-proBNP) assessment.
Results: In patients, right atrial (RA) minimal volume (34±8ml/m2 vs. 28±8 ml/m2, p=0.001) and late emp-
tying fraction were increased; RA early emptying fraction was decreased. Patients had longer right ventricular
(RV) deceleration time (0.24±0.10 vs. 0.13±0.04, pb0.001), reﬂecting impaired RV relaxation, and larger RV
volumes. Patients with end-diastolic forward ﬂow (EDFF) had larger RA and RV size, abnormal RA emptying,
higher NT-proBNP levels, higher VE/VCO2 slope (ventilatory response to carbon dioxide production), and the
most abnormal LV diastolic function (impaired compliance). Patients with abnormal RA emptying (reservoir
function b30% and pump function >24%) had higher NT-proBNP levels and worse exercise capacity. RA
minimal volume was associated with RV end-diastolic volume (r=0.35, p=0.013).
Conclusions: In TOF patients with moderate RV dilatation, abnormal bi-atrial function and biventricular diastolic
dysfunction are common. Abnormal RA emptying was associated with signs of impaired clinical condition, as
was the presence of EDFF. These parameters, together with RA enlargement, could serve as useful markers
for clinically relevant RV diastolic dysfunction.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Chronic pulmonary regurgitation (PR) with subsequent right ven-
tricular (RV) dilatation is an important cause of late morbidity and
mortality in patients long after surgical repair of tetralogy of Fallot
(TOF) [1–4]. Up to now, it remains difﬁcult to predict the course of
RV dilatation and deterioration in TOF patients, and the precisech grant from the Netherlands
dren's Hospital, Department of
060, 3000 CB, Rotterdam, The
72.
lbing).
Ltd. All rights reserved.indications and optimal timing to perform a pulmonary valve replace-
ment (PVR) have therefore not been fully clariﬁed.
Biventricular size and systolic functional parameters have been
studied extensively in TOF patients, but little information is available
on atrial size and function. The atria play a crucial role in the ﬁlling of
the ventricle during ventricular diastole. It has been reported that left
atrial (LA) enlargement reﬂects the burden of left ventricular (LV)
diastolic dysfunction and that LA volumes increase with the severity
of diastolic dysfunction [5]. This emphasizes the need for measure-
ment of atrial size and function if diastolic function is assessed.
Diastolic dysfunction may be important as a marker preceding
systolic dysfunction [6,7], but isolated diastolic dysfunction with
preserved ejection fraction (EF) may also be an independent parame-
ter inﬂuencing patient outcome [8]. The relationship between RV
Fig. 1. Contour tracing of atrial and ventricular borders in short axis orientation.
A) Right atrial and left atrial contours; B) right ventricular and left ventricular contours.
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patients [9–13], but relatively little is known on the effects of right
sided abnormalities on LV diastolic function.
Magnetic resonance imaging (MRI) is the gold standard technique
for the assessment of biventricular size and function [14], and it has
also been demonstrated to be an accurate tool for the analysis of atrial
size and function [15].
The aim of our study was to assess bi-atrial size and function in
patients after repair of tetralogy of Fallot and to evaluate the clinical
value of these parameters by relating them to biventricular systolic
and diastolic function, exercise capacity, electrocardiographic (ECG)
parameters, and N-terminal prohormone brain natriuretic peptide
(NT-proBNP) levels.
2. Methods
2.1. Patients
This study is part of a larger, prospective serial follow-up study, for which the in-
clusion criteria were: 1) surgical repair of tetralogy of Fallot without associated cardiac
lesions, 2) the availability of an MRI study at least 3 years before the current study.
Patients with more than mild tricuspid regurgitation or evidence of a residual
ventricular septal defect were excluded.
Fifty-four patients were included in the current cross-sectional study between
September 2007 and February 2010. Patients underwent an MRI study with imaging
of the atria, 12-lead ECG, 24-hour Holter monitoring, NT-proBNP assessment, and ex-
ercise testing, all on the same day.
Results ofMRI parameters were compared to a group of 30 healthy controls (15male,
31±7 years), within our center. Healthy controls were volunteers without cardiac
symptoms.
The study protocol conforms to the ethical guidelines of the 1975 Declaration of
Helsinki. Our study protocol was approved by the local Ethical Committee; all partici-
pants, and if required parents, gave written informed consent.
2.2. Magnetic resonance imaging
Cardiac MRI was performed at a Signa 1.5 Tesla system (General Electric, Milwaukee,
WI, USA) and an 8-channel phased-array cardiac surface coil. All patients weremonitored
by vector cardiogram gating and respiratorymonitoring. All imageswere obtained during
breath-hold in end-expiration. A multi-slice, multi-phase data set was acquired using
steady-state free precession cine imaging in a short axis direction, covering the whole
heart, including the atria. Typical imaging parameters were: repetition time 3.4 ms,
echo time 1.4 ms, ﬂip angle 45°, slice thickness 8–10 mm, inter-slice gap 1 mm, ﬁeld of
view 380×380 mm, and matrix 160×128 mm. Flow measurements of the pulmonary
valve were performed perpendicular to ﬂow, using a velocity-encoded MRI sequence.
Typical imaging parameters were: repetition time 4.5 ms, echo time 2.4 ms, ﬂip angle
18°, slice thickness 7 mm, ﬁeld of view 290×220 mm, andmatrix 256×128 mm. Velocity
encoding was set at 150 cm/s and was increased whenever phase aliasing occurred.
Analysis was performed on a commercially available Advanced Windows worksta-
tion (General Electric Medical Systems), equipped with the software packages MASS
and FLOW (Medis Medical Imaging Systems, Leiden, the Netherlands). Endocardial
and epicardial borders of both ventricles were manually traced in end-systole and
end-diastole. Endocardial borders of the right atrium (RA), LA, RV, and LV were subse-
quently deﬁned in all phases and all slices of the short axis set using a previously
described semi-automated full cardiac cycle contour detection method [16]. Contours
were manually corrected if necessary. The atrial appendages were included in the atrial
volumes. The superior and inferior caval veins, coronary sinus and pulmonary veins
were excluded at their junction to the atrium. Papillary muscles and trabeculations
were included in the ventricular cavity. The interventricular septum was included in
the LV mass. When the pulmonary valve was visible in the basal slice, contours were
drawn up to the junction with the pulmonary valve. All atrial data-sets were analyzed
by 1 observer (RP) and supervised by another observer (SL), who also analyzed all ven-
tricular data-sets and had 4 years of experience in cardiac contour tracing. Fig. 1 shows
bi-atrial and biventricular endocardial contour tracing.
2.3. MRI parameters
Time volume curves for the RA, LA, RV, and LV were acquired by summation of
the volumes of every slice of each phase. Additionally, time volume change curves
were reconstructed (Fig. 2). The terms systole and diastole always refer to ventricular
systole and ventricular diastole.
2.4. RA and LA function
The following parameters were assessed for RA and LA function (Fig. 2A, B), as de-
scribed by Riesenkampff and colleagues [17]: 1) maximal volume (max.vol); 2) minimal
volume (min.vol); 3) cyclic volume change, deﬁned as the difference between maximaland minimal atrial volume; 4) cyclic volume change function, which is the cyclic
volume change, expressed as percentage of maximal atrial volume; 5) reservoir function,
calculated by subtracting the minimal atrial volume at middiastole from the maximal
atrial volume, expressed as percentage of ventricular effective stroke volume (SV);
6) pump function, calculated by subtracting the minimal atrial volume from the maximal
atrial volume at middiastole, expressed as percentage of ventricular effective SV; 7) con-
duit function, calculated by subtraction of the sumof reservoir andpump volume from the
effective SV of the ventricle, expressed as percentage of ventricular effective SV; 8) early
emptying fraction, deﬁned as atrial volume decrease during the ﬁrst 1/3 of ventricular
diastole, expressed as percentage of the cyclic volume change; 9) early peak emptying
rate (EPER), deﬁned as the maximal atrial volume change in early ventricular diastole;
10) late emptying fraction, deﬁned as the decrease in atrial volume after the onset of atrial
contraction, expressed as percentage of the cyclic volume change; 11) late peak emptying
rate (LPER), deﬁned as the maximal atrial volume change in late ventricular diastole; and
12) E/A volume ratio, as the ratio of early emptying volume to late emptying volume.
Volumetric parameters were indexed for body surface area (BSA); EPER and LPER were
indexed for cyclic volume change.
2.5. RV and LV function
The following parameters were assessed for RV and LV systolic and diastolic func-
tion (Fig. 2C, D): 1) biventricular end-diastolic volume (EDV); 2) end-systolic volume
(ESV); 3) SV; 4) EF; 5) mass; 6) early ﬁlling fraction, deﬁned as ventricular volume
Fig. 2. Time volume curves and time volume changes curves for RA parameters and RV parameters. A) RA time volume curve; B) RA time volume change curve; C) RV time volume
curve; D) RV time volume change curve. Abbreviations: RA=right atrium; RV=right ventricle.
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early peak ﬁlling rate (EPFR), deﬁned as the maximal ventricular volume change in
early diastole; 8) deceleration time (Dt), which is the time from EPFR to the extrapola-
tion point of deceleration of ﬂow to the baseline; 9) atrial ﬁlling fraction, deﬁned as the
increase in ventricular volume after the onset of atrial contraction, expressed as per-
centage of ventricular SV; 10) atrial peak ﬁlling rate (APFR), deﬁned as the maximal
ventricular volume change in late diastole; and 11) E/A volume ratio, as the ratio of
early ﬁlling volume to atrial ﬁlling volume. Pulmonary regurgitation was expressed
as percentage of systolic SV in the main pulmonary artery. Additionally, RV effective
stroke volume (eff.SV) was calculated to correct for PR: RVeff.SV=RVSV−PR volume.
End-diastolic forward ﬂow (EDFF) was deﬁned as the presence of late diastolic forward
ﬂow in the pulmonary artery.
Volumes and mass were indexed for BSA; Dt for the RR-interval, and EPFR and
APFR were indexed for SV.Table 1
Characteristics of the study population and results of ECG parameters, NT-proBNP, and
exercise capacity.
Parameter All patients
(N=51)
Palliative shunt before corrective surgery 6 (12%)
Age at corrective surgery (years) 0.8 (0.1–9.4)
Transannular patch 41 (80%)
Age at study (years) 21 (±8)
Male (%) 32 (63%)
PVR patients 10 (20%)
BSA (m2) 1.79 (±0.25)
NYHA class I: 42 (82%)
II: 9 (18%)
Heart rate (beats/minute) 75 (±13)2.6. Clinical parameters
A standardized 12-lead ECG was obtained to determine QRS duration and QT inter-
val corrected for heart rate (QTc). A 24-hour Holter monitoring was performed on a
day with usual activities.
Blood samples were drawn from a peripheral vein after 30 minutes rest in supine
position. Plasma and serum were separated immediately after sample collection and
stored at −80 °C. NT-proBNP was measured using the following commercially avail-
able Elecsys kit: electrochemiluminescence immunoassay (Roche Diagnostics, Mann-
heim, Germany).
Patients performed a maximal bicycle exercise test on a Jaëger Oxycom Champion
System (Viasys Healthcare, Hoechberg, Germany). Workload was increased by
20 Watts per minute. Peak workload and peak oxygen uptake (peak VO2) were
recorded and expressed as percentages of predicted values [18,19]. The ventilatory re-
sponse to carbon dioxide production (VE/VCO2 slope) was obtained by linear regres-
sion analysis of the data acquired throughout the entire period of exercise.QRS duration (ms) 137 (±26)
QTc interval (ms) 434 (±36)
VT run (number of patients) 1 (2%)
SVT run (number of patients) 2 (4%)
NT-proBNP (pmol/l) 14 (±10)
Peak workload (%) 87 (±12)
Peak VO2 (%) 89 (±14)
VE/VCO2 slope 31 (±5)
Results are given as mean (standard deviation), as median (range) or as counts
(percentages).
Abbreviations: BSA=body surface area; ECG=electrocardiography; NT-proBNP=N-
terminal prohormone brain natriuretic peptide; NYHA=New York Heart Association;
PVR=pulmonary valve replacement; QTc=QT interval, corrected for heart rate;
SVT=supraventricular tachycardia; VE/VCO2=ventilatory response to carbon dioxide
production; peak VO2=peak oxygen uptake; VT=ventricular tachycardia.2.7. Statistical analysis
Continuous data were tested for normality with the Kolmogorov–Smirnov test.
Normally distributed data are expressed as mean (±standard deviation) and non-
normally distributed data as median (range). Differences between groups of
patients were evaluated using Student t-test or nonparametric tests, as appropriate.
Categorical data are expressed as counts (percentages) and differences between
groups of patients were evaluated with chi-square or Fisher exact test. To test the
potential clinical value of parameters of bi-atrial size and function on relevant out-
come parameters, correlations were assessed in all patients using linear regression
analysis.
Analyses were performed using the SPSS statistical software package version 17.0
(SPSS, Inc., USA). A p-value b0.05 was considered to indicate statistical signiﬁcance.3. Results
Fifty-four patients were included in our study. Three patients were
excluded because of incompleteMRI data. Characteristics of the remain-
ing 51 patients, and results of 12-lead ECG, 24-hour Holter monitoring,
NT-proBNP assessment, and exercise testing are displayed in Table 1.3.1. Patients vs. controls
Results of bi-atrial functional parameters are displayed in Table 2.
Compared to healthy controls, patients had a larger RA minimal
Table 2
Results of bi-atrial functional parameters.
Parameter RA LA
Controls
(N=30)
All patients
(N=51)
p-value
(a)
Controls
(N=30)
All patients
(N=51)
p-value
(a)
Maximal volume (ml/m2) 57 (±11) 55 (±10) ns 41 (±6) 33 (±6)a b0.001
Minimal volume (ml/m2) 28 (±8) 34 (±8)a 0.001 16 (±3) 15 (±4) ns
Cyclic volume change (ml/m2) 30 (±7) 21 (±4)a b0.001 26 (±5) 18 (±4)a b0.001
Cyclic volume change function (%) 52 (±8) 39 (±7)a b0.001 62 (±5) 56 (±6)a b0.001
Reservoir function (%) 41 (±10) 30 (±9)a b0.001 35 (±5) 26 (±6)a b0.001
Pump function (%) 21 (±5) 24 (±9)a 0.046 20 (±6) 16 (±6)a 0.002
Conduit function (%) 38 (±10) 46 (±12)a 0.003 46 (±6) 58 (±9)a b0.001
Early emptying fraction (%) 62 (±15) 52 (±17)a 0.008 64 (±12) 56 (±17)a 0.017
Late emptying fraction (%) 36 (±9) 51 (±16)a b0.001 40 (±10) 39 (±11) ns
E/A volume ratio 1.9 (±0.9) 1.1 (±0.5)a b0.001 1.7 (±0.6) 1.6 (±0.8) ns
EPER/cyclic volume change (/s) 2.0 (±0.5) 1.8 (±0.5) ns 2.2 (±0.5) 2.3 (±0.6) ns
LPER/cyclic volume change (/s) 1.3 (±0.5) 1.7 (±0.5)a b0.001 1.5 (±0.6) 1.4 (±0.5) ns
Results are given as mean (standard deviation).
Abbreviations: E/A volume ratio=ratio of early emptying volume to late emptying volume; EPER=early peak emptying rate; LA=left atrium; LPER=late peak emptying rate;
ns=not signiﬁcant; RA=right atrium.
a Signiﬁcantly different between patients and controls.
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and E/A volume ratio; the RA pump function and RA late emptying
fraction were higher. Patients had a lower LA maximal volume, LA
reservoir function, LA early emptying fraction, and LA pump function
than controls. Bi-atrial cyclic volume change function was lower in
patients than in controls.
Results of biventricular functional parameters are displayed in
Table 3. Patients had larger RV volumes than controls; RVeff.SV and
LVSV were smaller, and biventricular EF was lower than in controls.
Compared to healthy controls, patients had a lower RV EPFR, LV
early ﬁlling fraction, LV atrial ﬁlling fraction, and LV APFR; the LV
E/A volume ratio was higher. Biventricular Dt was longer in patients
than in controls.
3.2. Patients with EDFF vs. patients without EDFF
Results for patients with EDFF vs. patients without EDFF are dis-
played in Table 4: only signiﬁcant results are shown. RA maximal
volume and minimal volume were larger, and RA pump function
and RA late emptying fraction were higher in patients with EDFF
than in patients without EDFF. Patients with EDFF had more PR and
larger RV volumes than patients without EDFF. The LV E/A volumeTable 3
Results of biventricular functional parameters.
RV
Parameter Controls
(N=30)
All patients
(N=51)
PR (%) N/A 28 (±18)a
EDV (ml/m2) 94 (±17) 138 (±34)a
ESV (ml/m2) 42 (±11) 72 (±22)a
SV (ml/m2) 52 (±8) 66 (±15)a
Effective SV (ml/m2) 52 (±8) 46 (±7)a
EF (%) 56 (±6) 48 (±5)a
Mass (g/m2) 16 (±4) 25 (±7)a
Mass/EDV ratio 0.17 (±0.02) 0.18 (±0.04)
Early ﬁlling fraction (%) 38 (±12) 37 (±10)
Atrial ﬁlling fraction (%) 31 (±10) 33 (±14)
E/A volume ratio 1.3 (±0.7) 1.6 (±1.3)
EPFR/SV (/s) 1.6 (±0.4) 1.3 (±0.3)a
Dt/RR interval ratio 0.13 (±0.04) 0.24 (±0.10)a
APFR/SV (/s) 1.2 (±0.4) 1.0 (±0.4)
Results are given as mean (standard deviation).
Abbreviations: APFR=atrial peak ﬁlling rate; Dt=deceleration time; E/A volume ratio=
EF=ejection fraction; EPFR=early peak ﬁlling rate; ESV=end-systolic volume; N/A=n
RV=right ventricle; SV=stroke volume.
a Signiﬁcantly different between patients and controls.ratio, the NT-proBNP level, and the VE/VCO2 slope were higher in
patients with EDFF than in patients without EDFF.3.3. Patients with “normal” RA emptying vs. patients with “abnormal” RA
emptying
Since results of bi-atrial parameters showed that RA emptying
was abnormal in patients (lower RA reservoir function and RA early
emptying fraction; higher RA pump function and RA late emptying
fraction), we subdivided our 51 patients into 2 groups to evaluate the
clinical consequences of abnormal RA emptying: 1) patients with RA
reservoir function >30% and RA pump function b24% (“normal” RA
emptying) (N=15); and 2) patients with RA reservoir function b30%
and RA pump function >24% (“abnormal” RA emptying) (N=36).
These cut-off values for RA reservoir function and RA pump function
were based on the mean values of all patients. Results are displayed in
Table 5.
EDFF in the pulmonary artery was more present in patients with
“abnormal” RA emptying than in patients with “normal” RA emptying.
RV mass tended to be larger in patients with “abnormal” RA emptying,
but this was not signiﬁcant. Patients with “abnormal” RA emptying hadLV
p-value
(a)
Controls
(N=30)
All patients
(N=51)
p-value
(a)
b0.001 N/A N/A
b0.001 88 (±12) 86 (±13) ns
b0.001 36 (±7) 38 (±9) ns
b0.001 51 (±8) 47 (±7)a 0.014
0.003 51 (±8) 47 (±7)a 0.014
b0.001 58 (±4) 55 (±5)a 0.008
b0.001 51 (±11) 54 (±9) ns
ns 0.59 (±0.08) 0.63 (±0.09)a 0.021
ns 54 (±17) 46 (±18)a 0.046
ns 23 (±8) 17 (±10)a 0.006
ns 2.7 (±1.3) 4.2 (±3.7)a 0.008
0.003 1.9 (±0.3) 1.9 (±0.3) ns
b0.001 0.14 (±0.03) 0.16 (±0.04)a 0.012
ns 0.9 (±0.4) 0.6 (±0.3)a b0.001
ratio of early ﬁlling volume to atrial ﬁlling volume; EDV=end-diastolic volume;
ot applicable; ns=not signiﬁcant; LV=left ventricle; PR=pulmonary regurgitation;
Table 4
Results for patients with and without end-diastolic forward ﬂow.
Characteristic Patients with EDFF
(N=31)
Patients without EDFF
(N=20)
p-value
(a)
PVR patients 2 (6%)a 8 (40%) 0.008
RA maximal volume (ml/m2) 58 (±10)a 52 (±9) 0.047
RA minimal volume (ml/m2) 36 (±9)a 31 (±6) 0.047
RA pump function (%) 27 (±8)a 20 (±7) 0.003
RA conduit function (%) 43 (±13)a 51 (±9) 0.014
RA late emptying fraction (%) 54 (±15)a 45 (±15) 0.039
LA cyclic volume change (ml/m2) 20 (±4)a 16 (±4) 0.004
LA cyclic volume change function (%) 58 (±6)a 52 (±5) 0.001
LA reservoir function (%) 28 (±6)a 24 (±6) 0.023
LA pump function (%) 17 (±6)a 13 (±4) 0.013
LA conduit function (%) 55 (±9)a 63 (±6) b0.001
PR (%) 36 (±13)a 15 (±17) b0.001
RVEDV (ml/m2) 151 (±33)a 120 (±27) 0.001
RVESV (ml/m2) 79 (±22)a 63 (±19) 0.010
RVSV (ml/m2) 72 (±14)a 57 (±12) b0.001
RV mass/EDV ratio 0.17 (±0.04)a 0.19 (±0.03) 0.045
LV E/A volume ratio 5.0 (±4.1)a 2.9 (±2.5) 0.032
NT-proBNP (pmol/l) 16 (±10)a 9 (±9) 0.015
VE/VCO2 slope 32 (±4)a 28 (±6) 0.014
Results are given as mean (standard deviation) or as counts (percentages).
Abbreviations: EDFF=end-diastolic forward ﬂow; other abbreviations as in Tables 1–3.
a Signiﬁcantly different between patients with and without EDFF.
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with “normal” RA emptying.
3.4. Correlations
Relevant associations between RA parameters and parameters of
clinical condition and RV size are displayed in Fig. 3. RA minimal
volume was positively associated with RVEDV (Fig. 3A); RA cyclic
volume change function was negatively associated with RVEDV
(Fig. 3B). A higher RA late emptying fraction was correlated with a
higher RVEDV and a higher NT-proBNP level (Fig. 3C, E). A lower RA
early emptying fraction was associated with a longer QRS duration
(Fig. 3D); a higher RA E/A volume ratio was associated with a higher
peak VO2 (Fig. 3F).
4. Discussion
This cross-sectional study in patients after surgical repair of tetral-
ogy of Fallot demonstrated that in patients with adequate clinical
condition, moderately dilated right ventricles and mildly impairedTable 5
Results for patients with “normal” and “abnormal” RA emptying.
Characteristic “Normal” RA emptying
(N=15)
EDFF 6 (40%)
RA reservoir function (%) 37 (±5)
RA pump function (%) 17 (±4)
RA late emptying fraction (%) 35 (±11)
RA E/A volume ratio 1.6 (±0.6)
RA EPER/cyclic volume change (/s) 2.3 (±0.4)
RA LPER/cyclic volume change (/s) 1.3 (±0.3)
RVEDV (ml/m2) 132 (±32)
RV mass (g/m2) 22 (±4)
LV E/A volume ratio 3.1 (±2.7)
NT-proBNP (pmol/l) 7 (±7)
Peak workload (%) 95 (±15)
Peak VO2 (%) 94 (±16)
Results are given as mean (standard deviation), as median (range) or as counts (percentag
a Signiﬁcantly different between patients with “normal” and “abnormal” RA emptying. Abiventricular systolic function, bi-atrial size and function are clearly
abnormal. The RA showed a larger minimal volume as well as reduced
early emptying and increased late emptying, while the LA showed
diminished ﬁlling and decreased emptying. The RV showed signs
of impaired relaxation, while the LV showed signs of impaired com-
pliance, particularly in patients with EDFF and in patients with
“abnormal” RA emptying. “Abnormal” RA emptying was related to
signs of impaired clinical condition, as was the presence of EDFF.
Furthermore, larger RA size was associated with larger RV size.
In our patients, RA reservoir function and RA early emptying were
diminished, which is in agreement with results of a recent study by
Riesenkampff et al. [17]. We argue that RA early emptying is in com-
petition with simultaneous inﬂow in the RV of pulmonary regurgitant
backﬂow. This might also explain the normal ﬁlling of the RV in early
diastole, despite signs of abnormal RV relaxation. These limitations to
early RA emptying explain the observation that RA reservoir function
and RA early emptying fraction are decreased and RA pump function
and RA late emptying fraction are increased. “Abnormal” RA emptying
was related to signs of impaired clinical condition, since patients with
“abnormal”RA emptyinghad a higherNT-proBNP level, a lower exercise“Abnormal” RA emptying
(N=36)
p-value
(a)
25 (69%) 0.050
27 (±9)a b0.001
27 (±8)a b0.001
58 (±12)a b0.001
0.9 (±0.4)a 0.001
1.7 (±0.4)a b0.001
1.9 (±0.4)a b0.001
141 (±35) ns
(p=0.40)
26 (±8) ns
(p=0.074)
4.7 (±4.0) ns
(p=0.19)
16 (±10)a 0.002
84 (±9)a 0.017
87 (±12) ns
(p=0.099)
es).
bbreviations: as in Tables 1–4.
Fig. 3. Correlations between RA parameters and parameters of clinical condition and RV size. Correlation between: A) RA minimal volume and RVEDV; B) RA cyclic volume change
function and RVEDV; C) RA late emptying fraction and RVEDV; D) RA early emptying fraction and QRS duration; E) RA late emptying fraction and NT-proBNP level; F) RA E/A
volume ratio and peak VO2. Abbreviations: E/A volume ratio=ratio of early emptying volume to late emptying volume; NT-proBNP=N-terminal prohormone brain natriuretic
peptide; RA=right atrium; RVEDV=right ventricular end-diastolic volume; peak VO2=peak oxygen uptake.
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with “normal” RA emptying (Table 5, Fig. 3C–F).
In our patients with an important amount of PR, the marked RV
dilatation and mildly decreased RV systolic function was not unex-
pected. Except for the signs of impaired RV relaxation in our patients,
i.e. prolonged RV deceleration time and lower RV EPFR, RV diastolic
functional parameters were comparable between our patients and
healthy controls. Surprisingly, no major differences in RV diastolic
functional parameters could be observed between patients with
EDFF and patients without EDFF. Whether these observations repre-
sent true normal diastolic function or a pseudonormal state [7] can-
not be directly determined from our data. Increased RA size has
been related to increased RV end-diastolic pressure [20]. We specu-
late that the higher RA maximal and minimal volume, and the higher
RV volumes that we found in our patients with EDFF relate to in-
creased RV end-diastolic pressure. This would point towards abnor-
mal RV diastolic function in these patients, which is compatible to
the abnormal ﬁnding of EDFF. We have previously demonstrated
that with dobutamine stress testing, impaired RV diastolic function
is a common ﬁnding even in TOF patients with few signs of abnormal
RV diastolic function at rest [21]. Assessment of RA size and function
may be helpful in clinical practice to identify abnormal RV diastolic
function.
End-diastolic forward ﬂow has been recognized as sign of restric-
tion to RV ﬁlling, but reports have been equivocal about the effects
of EDFF on clinical outcome. Some studies have shown beneﬁcial
effects with regard to RV size and clinical condition in patients with
EDFF [9,22], but other studies have reported that EDFF should beinterpreted as a negative sign [10,11,13]. The latter is in agreement
with our results, as we found that patients with EDFF had more PR,
more RV dilatation, higher NT-proBNP levels, and a higher VE/VCO2
slope than patients without EDFF. Lu et al. argued that the differences
in effects of EDFF can be explained by the era of treatment of the dif-
ferent patient populations [11]. In the patients who are operated at a
younger age, according to current strategies, the presence of EDFF
might reﬂect an overdistended ventricle due to poor compliance
from excessive RV dilatation, rather than the traditional deﬁnition
of RV restriction that represents restricted ﬁlling and a decreased
RV volume [11].
In our patients, LA maximal volume was lower than in healthy
controls. We assume that this reduced LA size is caused by the
lower RV effective SV, and subsequently reduced LA ﬁlling. Left atrial
emptying was also lower than in healthy controls, which presumably
relates to the LV diastolic functional abnormalities that we found.
The LV showed signs of impaired relaxation (prolonged decelera-
tion time), and of impaired compliance, as the LV E/A ratio was signif-
icantly higher in patients than in healthy controls. Left ventricular
diastolic dysfunction is present in up to 25% of adult patients with
repaired TOF [23]. The presence of reduced LV compliance might re-
late to the ﬁnding that LV mass/EDV ratio was increased. This might
represent chronic underﬁlling of the LV, but LV volumetric data in
our patients do not support this hypothesis. More likely, reduced LV
compliance relates to LV ﬁbrosis [24], LV dyssynchrony [25], and
abnormal RV–LV diastolic interaction through the interventricular
septum [25–28]. The presence of adverse right-to-left interactions
is supported by our observation that patients with a large RA and
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Furthermore, it has been reported that RV pressure overload causes
reduced LV compliance through mechanical and molecular effects
on the septum and LVmyocardium [8]. Our data suggest a relation be-
tween RV volume overload and reduced LV compliance as well, since
reduced LV compliance was particularly seen in our patients with
EDFF, who had a more volume overloaded RV than patients without
EDFF. This points towards the clinical relevance of EDFF, a marker
that can be easily obtained with different imaging techniques [10].
Supraventricular and ventricular arrhythmias are common after
TOF repair [23,29]. The risk of arrhythmias, particularly of intraatrial
reentrant tachycardia, increases with larger RA size [23]. Left atrial
size, among other factors, has been related to increased risk for
atrial ﬁbrillation in an adult TOF population [23,29]. Left ventricular
diastolic function and PR are some of the factors increasing the risk
for ventricular arrhythmias [2,23]. Despite the presence of several of
these factors in our patients, tachyarrhythmias were uncommon. An
older age at repair and increasing age have been associated with a
higher risk of atrial and ventricular arrhythmias, [2,23,29], which
might explain the lower prevalence of arrhythmias in our relatively
young patient population operated at young age.
4.1. Limitations
Information about invasive pressure measurements is lacking
since our study was noninvasive. Invasive pressure measurements
could have given more insight into biventricular diastolic functional
parameters and its implications.
Our study has been performed in adolescents and young adults
operated on according to current surgical strategies. Our results may
therefore be not representative for older TOF patients.
5. Conclusions
In TOF patients with moderately dilated right ventricles and mildly
impaired biventricular systolic function, bi-atrial function is clearly
impaired and abnormal biventricular diastolic function is common.
Right atrial enlargement, impaired RA early emptying and increased
RA late emptying were related to signs of impaired clinical condition,
as was the presence of EDFF. Assessment of RV diastolic dysfunction
in the presence of PR is complex: the presence of EDFF, RA enlargement,
and abnormal RA emptying may serve as useful markers for clinically
relevant RV diastolic dysfunction in TOF patients, which emphasizes
the need for routine assessment of these parameters.
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